메뉴 건너뛰기




Volumn 21, Issue 4, 2013, Pages 240-246

Treatment of vancomycin-resistant enterococcal bacteremia in an observational cohort of neutropenic oncology patients daptomycin versus linezolid

Author keywords

Bacteremia; Daptomycin; Linezolid; Neutropenic; Vancomycin resistant enterococcus; VRE

Indexed keywords

DAPTOMYCIN; LINEZOLID; VANCOMYCIN;

EID: 84888346223     PISSN: 10569103     EISSN: 15369943     Source Type: Journal    
DOI: 10.1097/IPC.0b013e31827ce847     Document Type: Article
Times cited : (8)

References (34)
  • 1
    • 0023808730 scopus 로고
    • Plasmid-mediated resistance to vancomycin and teicoplanin in enterococcus faecium
    • Leclercq R, Derlot E, Duval J, et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988;319(3):157-161.
    • (1988) N Engl J Med , vol.319 , Issue.3 , pp. 157-161
    • Leclercq, R.1    Derlot, E.2    Duval, J.3
  • 2
    • 0023837814 scopus 로고
    • Vancomycin- resistant enterococci
    • Uttley AH, Woodford N, Johnson AP, et al. Vancomycin- Resistant Enterococci. Lancet. 1988;1(8575-6):57-58.
    • (1988) Lancet , vol.1 , Issue.8575-8576 , pp. 57-58
    • Uttley, A.H.1    Woodford, N.2    Johnson, A.P.3
  • 4
    • 0037190708 scopus 로고    scopus 로고
    • Health and economic outcomes of vancomycin-resistant enterococci
    • Carmeli Y, Eliopoulos G, Mozaffari E, et al. Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med. 2002;162:2223-2228.
    • (2002) Arch Intern Med , vol.162 , pp. 2223-2228
    • Carmeli, Y.1    Eliopoulos, G.2    Mozaffari, E.3
  • 5
    • 0141869007 scopus 로고    scopus 로고
    • Outcomes associated with vancomycin-resistant enterococci: A meta-analysis
    • Saldago CD, Farr BM. Outcomes associated with vancomycin-resistant enterococci: A meta-analysis. Infect Control Hosp Epidemiol. 2003;24(9):690-698.
    • (2003) Infect Control Hosp Epidemiol , vol.24 , Issue.9 , pp. 690-698
    • Saldago, C.D.1    Farr, B.M.2
  • 6
    • 49549094298 scopus 로고    scopus 로고
    • The burden of vancomycin-resistant enterococcal infections in us hospitals, 2003 to 2004
    • Reik R, Tenover FC, Klein E, et al. The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004. Diagn Microbiol Infect Dis. 2008;62:81-85.
    • (2008) Diagn Microbiol Infect Dis , vol.62 , pp. 81-85
    • Reik, R.1    Tenover, F.C.2    Klein, E.3
  • 7
    • 0003184226 scopus 로고
    • Sep 22, (RR-12)
    • MMWR Recomm Rep. 1995 Sep 22;44(RR-12):1-13.
    • (1995) MMWR Recomm Rep , vol.44 , pp. 1-13
  • 9
    • 0031925669 scopus 로고    scopus 로고
    • Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: Comparison of clinical features and outcomes
    • Lucus GM, Lechtzin N, Puryear D, et al. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis. 1998;26:1127-1133.
    • (1998) Clin Infect Dis , vol.26 , pp. 1127-1133
    • Lucus, G.M.1    Lechtzin, N.2    Puryear, D.3
  • 10
    • 0033128729 scopus 로고    scopus 로고
    • Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality
    • Lautenbach E, Bilker WB, Brennan PJ. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol. 1999;20:318-323.
    • (1999) Infect Control Hosp Epidemiol , vol.20 , pp. 318-323
    • Lautenbach, E.1    Bilker, W.B.2    Brennan, P.J.3
  • 11
    • 77249176077 scopus 로고    scopus 로고
    • Outcomes of invasive infection due to vancomycin-resistant enterococcus faecium during a recent outbreak
    • Theilacker C, Jonas D, Huebner J, et al. Outcomes of invasive infection due to vancomycin-resistant Enterococcus faecium during a recent outbreak. Infection. 2009;37:540-543.
    • (2009) Infection , vol.37 , pp. 540-543
    • Theilacker, C.1    Jonas, D.2    Huebner, J.3
  • 12
    • 42549108292 scopus 로고    scopus 로고
    • Risk of vancomycin-resistant enterococcus (vre) bloodstream infection among patients colonized with vre
    • Olivier CN, Blake RK, Steed LL, et al. Risk of vancomycin-resistant enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect Control Hosp Epidemiol. 2008;29:404-409.
    • (2008) Infect Control Hosp Epidemiol , vol.29 , pp. 404-409
    • Olivier, C.N.1    Blake, R.K.2    Steed, L.L.3
  • 13
    • 78651508828 scopus 로고    scopus 로고
    • Incidence of vancomycin-resistant enterococci (vre) infection in high-risk febrile neutropenic patients colonized with vre
    • E-pub Jan 13, 2010
    • Bossaer JB, Hall PD, Garrett-Mayer E. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Support Care Cancer. 2010;19(2):231-237. E-pub Jan 13, 2010.
    • (2010) Support Care Cancer , vol.19 , Issue.2 , pp. 231-237
    • Bossaer, J.B.1    Hall, P.D.2    Garrett-Mayer, E.3
  • 14
    • 77957753370 scopus 로고    scopus 로고
    • The changing epidemiology of vancomycin-resistant enterococcus (vre) bacteremia in allogeneic hematopoietic stem cell transplant (hsct) recipients
    • E-pub May 26, 2010
    • Kamboj M, Chung D, Seo SK, et al. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant. 2010;16(11):1576-1581. E-pub May 26, 2010.
    • (2010) Biol Blood Marrow Transplant , vol.16 , Issue.11 , pp. 1576-1581
    • Kamboj, M.1    Chung, D.2    Seo, S.K.3
  • 15
    • 0036189636 scopus 로고    scopus 로고
    • Risk factors for vancomycin-resistant enterococcus (vre) infection in colonized patients with cancer
    • Husni R, Hachem R, Hanna H, et al. Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer. Infect Control Hosp Epidemiol. 2002;23:102-103.
    • (2002) Infect Control Hosp Epidemiol , vol.23 , pp. 102-103
    • Husni, R.1    Hachem, R.2    Hanna, H.3
  • 16
    • 0030831050 scopus 로고    scopus 로고
    • Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (vre) in vre-colonized patients with acute leukemia
    • Roghmann MC, McCarter RJ Jr, Brewrink J, et al. Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia. Clin Infect Dis. 1997;25:1056-1059.
    • (1997) Clin Infect Dis , vol.25 , pp. 1056-1059
    • Roghmann, M.C.1    Mccarter Jr., R.J.2    Brewrink, J.3
  • 17
    • 34547817285 scopus 로고    scopus 로고
    • Vancomycin-resistant enterococcus faecium in patients with hematologic malignancy: Patients with acute myeloid leukemia are at high-risk
    • Worth LJ, Thursky KA, Seymour JF, et al. Vancomycin-resistant Enterococcus faecium in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol. 2007;79:226-233.
    • (2007) Eur J Haematol , vol.79 , pp. 226-233
    • Worth, L.J.1    Thursky, K.A.2    Seymour, J.F.3
  • 18
    • 22544433208 scopus 로고    scopus 로고
    • Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptibility enterococcal bloodstream infections: A meta-analysis
    • DiazGranados CA, Zimmer SM, Klein M, et al. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptibility enterococcal bloodstream infections: A meta-analysis. Clin Infect Dis. 2005;41:327-333.
    • (2005) Clin Infect Dis , vol.41 , pp. 327-333
    • Diazgranados, C.A.1    Zimmer, S.M.2    Klein, M.3
  • 19
    • 40249117000 scopus 로고    scopus 로고
    • Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients
    • Zirakzadeh A, Gastineau DA, Mandrekar JN, et al. Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2008;41:385-392.
    • (2008) Bone Marrow Transplant , vol.41 , pp. 385-392
    • Zirakzadeh, A.1    Gastineau, D.A.2    Mandrekar, J.N.3
  • 20
    • 13444288108 scopus 로고    scopus 로고
    • Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection
    • DiazGranados C, Jernigan J. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis. 2005;191:588-595.
    • (2005) J Infect Dis , vol.191 , pp. 588-595
    • Diazgranados, C.1    Jernigan, J.2
  • 21
    • 34248360771 scopus 로고    scopus 로고
    • Daptomycin in the treatment of vancomycin-resistant enterococcus faecium bacteremia in neutropenic patients
    • Poutsiaka DD, Skiffington S, Miller KB, et al. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients. J Infect. 2007;54:567-571.
    • (2007) J Infect , vol.54 , pp. 567-571
    • Poutsiaka, D.D.1    Skiffington, S.2    Miller, K.B.3
  • 22
    • 34247148461 scopus 로고    scopus 로고
    • Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogenic hematopoietic stem cell transplant
    • Weinstock DM, Conlon M, Iovino C, et al. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogenic hematopoietic stem cell transplant. Biol Blood Marrow Transplant. 2007;13:615-621.
    • (2007) Biol Blood Marrow Transplant , vol.13 , pp. 615-621
    • Weinstock, D.M.1    Conlon, M.2    Iovino, C.3
  • 23
    • 83555172636 scopus 로고    scopus 로고
    • Outcomes of therapy: Vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients
    • E-pub 2010 Nov 26, 2010
    • Kraft S, Mackler E, Schlickman P, et al. Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients. Support Care Cancer. 2011;19(12):1969-1974. E-pub 2010 Nov 26, 2010.
    • (2011) Support Care Cancer , vol.19 , Issue.12 , pp. 1969-1974
    • Kraft, S.1    Mackler, E.2    Schlickman, P.3
  • 24
    • 84857795628 scopus 로고    scopus 로고
    • Vancomycin-resistant enterococcus bacteremia: An evaluation of treatment with linezolid or daptomycin
    • doi: 10.1002/jhm.994. E-pub 2011 Nov 10, 2011
    • Twilla JD, Finch CK, Usery JB, et al. Vancomycin-resistant Enterococcus bacteremia: An evaluation of treatment with linezolid or daptomycin. J Hosp Med. 2012;7(3):243-248. doi: 10.1002/jhm.994. E-pub 2011 Nov 10, 2011.
    • (2012) J Hosp Med , vol.7 , Issue.3 , pp. 243-248
    • Twilla, J.D.1    Finch, C.K.2    Usery, J.B.3
  • 25
    • 0037767160 scopus 로고    scopus 로고
    • Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant gram-positive infections in cancer patients with neutropenia
    • Smith PF, Birmingham MC, Noskin GA, et al. Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant gram-positive infections in cancer patients with neutropenia. Ann Oncol. 2003;14:795-801.
    • (2003) Ann Oncol , vol.14 , pp. 795-801
    • Smith, P.F.1    Birmingham, M.C.2    Noskin, G.A.3
  • 26
    • 33144464478 scopus 로고    scopus 로고
    • Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer
    • Jaksic B, Martinelli G, Perez-Oteyza J, et al. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer. Clin Infect Dis. 2006;42:597-607.
    • (2006) Clin Infect Dis , vol.42 , pp. 597-607
    • Jaksic, B.1    Martinelli, G.2    Perez-Oteyza, J.3
  • 27
    • 80051676875 scopus 로고    scopus 로고
    • Vancomycin-resistant enterococcal bacteraemia and daptomycin: Are higher doses necessary?
    • E-pub Jun 22, 2011
    • King EA, McCoy D, Desai S, et al. Vancomycin-resistant enterococcal bacteraemia and daptomycin: Are higher doses necessary? J Antimicrob Chemother. 2011;66(9):2112-2118. E-pub Jun 22, 2011.
    • (2011) J Antimicrob Chemother , vol.66 , Issue.9 , pp. 2112-2118
    • King, E.A.1    McCoy, D.2    Desai, S.3
  • 28
    • 39349084481 scopus 로고    scopus 로고
    • Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant enterococcus bacteremia
    • Erlandson KM, Sun J, Iwen PC, et al. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia. Clin Infect Dis. 2008;46:30-36.
    • (2008) Clin Infect Dis , vol.46 , pp. 30-36
    • Erlandson, K.M.1    Sun, J.2    Iwen, P.C.3
  • 29
    • 61349182487 scopus 로고    scopus 로고
    • Vancomycin-resistant enterococci bacteremia: Risk factors for mortality and influence of antimicrobial therapy on clinical outcome
    • Han SH, Chin BS, Lee HS, et al. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome. J Infect. 2009;58:182-190.
    • (2009) J Infect , vol.58 , pp. 182-190
    • Han, S.H.1    Chin, B.S.2    Lee, H.S.3
  • 30
    • 38049141184 scopus 로고    scopus 로고
    • Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes
    • Zuckermann J, Moreira LB, Stoll P, et al. Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes. Ann Hematol. 2008;87(2):139.
    • (2008) Ann Hematol , vol.87 , Issue.2 , pp. 139
    • Zuckermann, J.1    Moreira, L.B.2    Stoll, P.3
  • 31
    • 0242266613 scopus 로고    scopus 로고
    • Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis
    • Harbarth S, Garbino J, Pugin J, et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115(7):529-535.
    • (2003) Am J Med , vol.115 , Issue.7 , pp. 529-535
    • Harbarth, S.1    Garbino, J.2    Pugin, J.3
  • 32
    • 37549020378 scopus 로고    scopus 로고
    • Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008
    • Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36(1):296-327.
    • (2008) Crit Care Med , vol.36 , Issue.1 , pp. 296-327
    • Dellinger, R.P.1    Levy, M.M.2    Carlet, J.M.3
  • 33
    • 70350463588 scopus 로고    scopus 로고
    • Effectiveness of treatments for severe sepsis: A prospective multicenter observational study
    • Ferrer R, Artigas A, Suarez D, et al. Effectiveness of treatments for severe sepsis: A prospective multicenter observational study. Am J Respir Crit Care Med. 2009;180(9):861-866.
    • (2009) Am J Respir Crit Care Med , vol.180 , Issue.9 , pp. 861-866
    • Ferrer, R.1    Artigas, A.2    Suarez, D.3
  • 34
    • 79951816939 scopus 로고    scopus 로고
    • Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america
    • Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):427-431.
    • (2011) Clin Infect Dis , vol.52 , Issue.4 , pp. 427-431
    • Freifeld, A.G.1    Bow, E.J.2    Sepkowitz, K.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.